Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Pfizer
The 133rd Sale Featuring State Of The Art Biopharma R&D Lab Equipment From The World’s Premier Pharmaceutical Manufacturer!

Starting: Apr 23rd, 2024 7:00am EDT

Ending: Apr 25th, 2024 12:00pm EDT

Immediately Accepting Bids
PSS
Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Apr 18th, 2024 7:00am PDT

Ending: Apr 19th, 2024 9:00am PDT

Immediately Accepting Bids
1859 Inc
Online Auction Featuring Late Model Surplus Assets of 1859, Inc., A State of the Art Drug Discovery Company! San Diego, CA.

Starting: Apr 9th, 2024 7:00am PDT

Ending: Apr 10th, 2024 9:00am PDT

Immediately Accepting Bids
Instil Bio (UK)
Sale #3: Global Online Auction of Late Model Equipment From Clinical Stage Biopharmaceutical Facility! Manchester & Alderley Edge, UK.

Starting: Apr 2nd, 2024 7:00am BST

Ending: Apr 3rd, 2024 10:00am BST

Immediately Accepting Bids
Pfizer
The 132nd Sale Featuring State Of The Art Biopharma R&D Lab Equipment From The World’s Premier Pharmaceutical Manufacturer!

Starting: Mar 26th, 2024 7:00am EDT

Ending: Mar 28th, 2024 10:00am EDT

Immediately Accepting Bids
Kincell
Online Auction Featuring Late Model Lab Equipment Assets Surplus To Future Needs Of A CDMO! Gainesville, FL.

Starting: Mar 21st, 2024 7:00am EDT

Ending: Mar 22nd, 2024 12:00pm EDT

Immediately Accepting Bids
Avid
Online Auction Featuring Quality Biologics Manufacturing and Lab Equipment From A Leading CDMO! Tustin, CA.

Starting: Mar 19th, 2024 7:00am PDT

Ending: Mar 20th, 2024 9:00am PDT

Immediately Accepting Bids
PSS
Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Mar 11th, 2024 7:00am PDT

Ending: Mar 12th, 2024 9:00am PDT

Immediately Accepting Bids
Phenomic
Online Auction Featuring Quality Lab Equipment From a Canadian Based Machine Learning Biotech Company! Toronto, Canada.

Starting: Mar 11th, 2024 7:00am EDT

Ending: Mar 12th, 2024 11:00am EDT

Immediately Accepting Bids
VistaPharm
Online Auction Featuring Quality Pharmaceutical Process & Manufacturing Equipment Surplus To Future Needs of VistaPharm. Largo, FL.

Starting: Feb 27th, 2024 7:00am EDT

Ending: Feb 28th, 2024 12:00pm EDT

Immediately Accepting Bids
Biogen
Online Auction Featuring Late Model Biotech Lab Equipment From One of Biogen’s Reata Sites! Irving, TX.

Starting: Feb 22nd, 2024 7:00am CDT

Ending: Feb 23rd, 2024 10:00am CDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.